Analysts Offer Insights on Healthcare Companies: Owlet (OWLT) and Becton Dickinson (BDX)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Owlet (OWLT) and Becton Dickinson (BDX).
Easter Sale - 70% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Owlet (OWLT)
Northland Securities analyst Owen Rickert assigned a Buy rating to Owlet today and set a price target of $15.00. The company’s shares closed last Monday at $5.10.
According to TipRanks.com, Rickert is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
Currently, the analyst consensus on Owlet is a Strong Buy with an average price target of $14.00, which is a 170.3% upside from current levels. In a report released today, William Blair also maintained a Buy rating on the stock.
See the top stocks recommended by analysts >>
Becton Dickinson (BDX)
In a report released today, Travis Steed from Bank of America Securities reiterated a Hold rating on Becton Dickinson, with a price target of $221.00. The company’s shares closed last Monday at $155.32.
According to TipRanks.com, Steed is a 3-star analyst with an average return of
Becton Dickinson has an analyst consensus of Moderate Buy, with a price target consensus of $187.70, implying a 22.2% upside from current levels. In a report issued on March 23, TipRanks – OpenAI also reiterated a Hold rating on the stock with a $168.00 price target.
Read More on OWLT:
Disclaimer & DisclosureReport an Issue
- Leadership Transition and Insider Alignment Drive Renewed Confidence Behind Buy Rating on Owlet
- Closing Bell Movers: Health insurers rise on higher Medicare rate hike
- Owlet Reinstates Co‑Founder Kurt Workman as CEO
- Owlet CEO Harris resigns
- Owlet sees Q1 revenue at high end of $20M-$21M range, consensus $20.67M
